Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis

Fig. 1

Flow diagram of study design. Using a variety of data sources, this study examined the instruments proposed for actionable druggable proteins, specifically cis-pQTL and cis-eQTL, against MG GWAS summary statistics. Subsequently, further investigation was conducted on the MR associations that exhibited statistical significance and provided evidence for colocalization, aiming to identify immune-cell-specific effects

Back to article page